BIZZOZERO, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 217
EU - Europa 39
AS - Asia 28
AF - Africa 2
SA - Sud America 1
Totale 287
Nazione #
US - Stati Uniti d'America 214
IT - Italia 23
CN - Cina 22
DE - Germania 9
TW - Taiwan 5
CA - Canada 3
EG - Egitto 2
FR - Francia 2
CL - Cile 1
CZ - Repubblica Ceca 1
EU - Europa 1
FI - Finlandia 1
GB - Regno Unito 1
GR - Grecia 1
KR - Corea 1
NL - Olanda 1
Totale 288
Città #
Fairfield 37
Seattle 21
Buffalo 16
Ashburn 13
Milan 13
Wilmington 13
Woodbridge 13
Houston 10
Cambridge 9
Santa Cruz 8
Beijing 7
Ann Arbor 6
Munich 5
Taichung 3
Columbus 2
Essen 2
Las Vegas 2
Lishui 2
Los Angeles 2
Mountain View 2
Ottawa 2
Phoenix 2
Shanghai 2
Taipei 2
Aigaleo 1
Basking Ridge 1
Birmingham 1
Changsha 1
Chicago 1
Chongqing 1
Clearwater 1
Cosenza 1
Council Bluffs 1
Denton 1
Falkenstein 1
Guangzhou 1
Helsinki 1
Henderson 1
London 1
Mainz 1
Miami 1
Milpitas 1
Montréal 1
Mount Kisco 1
New York 1
Norwalk 1
Paderno Ponchielli 1
Ramsis 1
Redmond 1
Riva 1
Rome 1
San Diego 1
San Francisco 1
San Jose 1
Scranton 1
Serio 1
Wuhan 1
Yang 1
Zhengzhou 1
Totale 229
Nome #
Essential role for acid sphingomyelinase-inhibited autophagy in melanoma response to cisplatin, file dfa8b995-889b-748b-e053-3a05fe0a3a96 158
Modulation of Acid Sphingomyelinase in Melanoma Reprogrammes the Tumour Immune Microenvironment, file dfa8b994-715e-748b-e053-3a05fe0a3a96 139
THE ROLE OF ACID SPHINGOMYELINASE IN MELANOMA DEVELOPMENT AND PROGRESSION, file dfa8b98f-41c1-748b-e053-3a05fe0a3a96 9
Acid sphingomyelinase determines melanoma progression and metastatic behaviour via the microphtalmia-associated transcription factor signalling pathway, file dfa8b999-7069-748b-e053-3a05fe0a3a96 1
Totale 307
Categoria #
all - tutte 619
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 619


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201916 0 0 0 0 0 0 0 0 0 0 10 6
2019/202084 3 6 5 15 7 7 9 9 9 4 2 8
2020/202143 1 6 2 4 3 5 5 2 5 3 6 1
2021/202244 4 3 0 2 3 1 2 3 2 4 14 6
2022/202330 0 1 15 4 2 2 0 1 0 0 4 1
2023/202426 0 1 4 1 1 6 0 3 0 6 4 0
Totale 307